The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 04, 2020

Filed:

Dec. 09, 2016
Applicants:

Kyowa Hakko Kirin Co., Ltd, Tokyo, JP;

Kyushu University, National University Corporation, Fukuoka-shi, Fukuoka, JP;

Inventors:

Shin-ichiro Takayanagi, Tokyo, JP;

Hitomi Tomura, Takasaki, JP;

Tomonori Tawara, Tokyo, JP;

Yoshimasa Inagaki, Tokyo, JP;

Tsuguo Kubota, Tokyo, JP;

Koichi Akashi, Fukuoka, JP;

Yoshikane Kikushige, Fukuoka, JP;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/04 (2006.01); C12P 21/06 (2006.01); C12N 15/87 (2006.01); C12N 1/20 (2006.01); C12N 15/74 (2006.01); C07K 16/28 (2006.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2803 (2013.01); G01N 33/56972 (2013.01); C07K 2317/14 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/732 (2013.01); C07K 2317/92 (2013.01);
Abstract

Disclosed are an anti-human TIM-3 antibody having high ADCC activity or antibody fragment thereof by screening a monoclonal antibody or antibody fragment thereof which binds to the amino acid sequence of the extracellular region of TIM-3 or its three-dimensional structure and exhibits ADCC activity; a hybridoma which produces the antibody; a DNA encoding the antibody; a vector comprising the DNA; a transformant which is obtainable by introducing the vector; a method for producing the antibody or the antibody fragment thereof which comprises using the hybridoma or the transformant; and a therapeutic agent and a diagnostic agent comprising the antibody or the antibody fragment thereof as an active ingredient.


Find Patent Forward Citations

Loading…